False-negative results can occur with undetected mild hypercortisolemia or in the early stages of endocrinopathy, when the adrenal tumor does not exhibit corticotropin receptors, or through pre-analytical errors (Melián, 2017). This evidence concerns the gene MC2R and adrenal gland hyperfunction.